边际结构模型评估累积骨质疏松药物与感染关联的理赔数据分析
基于美国保险理赔数据库,纳入绝经后女性,采用边际结构模型评估双膦酸盐(BP)与其他骨质疏松药物联合治疗与感染发生率的关联。未加权Cox模型中BP治疗与总体感染风险呈正相关(IRR 1.15),加权MSM中呈负相关(IRR 0.79);严重感染在两种模型中均与较低风险相关。
要点
- 未加权Cox模型显示BP治疗与总体感染风险升高相关(IRR 1.15,95%CI 1.14-1.17)。
- 加权MSM显示BP治疗与总体感染风险降低相关(IRR 0.79,95%CI 0.77-0.81)。
- 严重感染在未加权Cox模型(IRR 0.79,95%CI 0.78-0.81)与加权MSM(IRR 0.71,95%CI 0.68-0.75)中均与较低风险相关。
核心结论
- 总体感染而非严重感染的效应估计在未加权模型与MSM之间的差异提示,涵盖不同疾病严重程度的复合结局分析可能更易受时间依赖混杂影响。
研究设计与样本
- 基于美国保险理赔数据库的队列分析,纳入绝经后女性,采用边际结构模型(MSM)评估双膦酸盐(BP)与其他骨质疏松药物联合治疗与感染发生率的关联。
- 通过建模治疗与删失过程并条件于既往治疗、基线及时间依赖协变量,估计稳定权重。
主要发现
- BP治疗与总体感染风险的关联在未加权Cox模型中为IRR 1.15(95%CI 1.14-1.17),在加权MSM中为IRR 0.79(95%CI 0.77-0.81),方向相反。
- BP治疗与严重感染风险的关联在未加权Cox模型中为IRR 0.79(95%CI 0.78-0.81),在加权MSM中为IRR 0.71(95%CI 0.68-0.75),均显示较低风险。
- 同时评估当前与既往治疗时得到相似结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Due to the suboptimal persistence to osteoporosis (OP) treatment, factors triggering treatment discontinuation/switching may be causing time-varying confounding. BP treatment was associated with the risk of overall infection in opposite directions in the unweighted Cox model versus the weighted MSM. The discrepancy of effect estimates for overall infection in the MSM suggested there may be time-varying confounding. INTRODUCTION: Due to the suboptimal persistence to osteoporosis (OP) treatment, factors triggering treatment discontinuation/switching may be affected by prior treatment and confound the subsequent treatment effect, causing time-varying confounding. METHODS: In a US insurance database, the association between joint treatment of bisphosphonates (BP) and other OP medication and the incidence of infections among postmenopausal women was assessed using a marginal structural model (MSM). Stabilized weights were estimated by modeling treatment and censoring processes conditioning on past treatment, and baseline and time-varying covariates. RESULTS: BP treatment was associated with the risk of overall infection in opposite directions in the unweighted Cox model {incidence rate ratio [IRR] [95% confidence interval (CI)] = 1.15 [1.14-1.17]} versus the weighted MSM [IRR (95% CI) = 0.79 (0.77-0.81)], but was consistently associated with a lower risk of serious infection in both the unweighted Cox model [IRR (95% CI] = 0.79 (0.78-0.81)) and the weighted MSM [IRR (95% CI) = 0.71 (0.68-0.75)]. Similar results were found when current and past treatments were simultaneously assessed. CONCLUSIONS: The discrepancy of effect estimates for overall but not serious infection comparing unweighted models and MSM suggested analyses of composite outcomes with a wide range of disease severity may be more susceptible to time-varying confounding.
引用
- Xue F, Goli V, Petraro P, et al. Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data. Osteoporos Int. 2017. PMID: 28685279. doi:10.1007/s00198-017-4129-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。